Independent psychedelic field guideEducational information — not medical adviceOur research standards
Home→Conditions→Depression
Condition path · 06 connected medicines

Depression

Mood · motivation · connection

The depression record includes an approved esketamine product, off-label ketamine care, controlled psilocybin trials, and much earlier work with DMT-related approaches. These medicines do not share one evidence base.

ASSOCIATION IS NOT A TREATMENT CLAIM

Medicines appear here because of current research, a specific established clinical context, or sustained public interest. Inclusion does not establish approval, suitability, safety, or effectiveness for an individual.

01 / START HERE

A condition is a starting point, not the whole story.

Depression is a name shared by several research populations. A trial may enroll people with major depressive disorder, treatment-resistant depression, recurrent episodes, or depressive symptoms within another illness. It may measure rapid symptom change, response several weeks later, daily functioning, remission, or relapse. Those choices define what the result can tell us.

EVIDENCE LENS

Esketamine has specific FDA-approved depression indications, while racemic ketamine is used off-label in psychiatric care. Psilocybin has a growing controlled-trial record with both positive and inconclusive findings. Research involving DMT, ayahuasca, and 5-MeO-DMT is earlier, smaller, and specific to particular formulations and settings.

FOR GUIDES & FACILITATORS

Begin with the person rather than the compound: the type and duration of depression, current medications, previous treatment, bipolar-spectrum or psychosis history, suicidality, physical health, support, and the care available after the acute experience.

02 / READ THE RECORD

Three very different evidence records

A medicine can appear on this page because it has an approved indication, an established off-label clinical role, controlled experimental evidence, or an early research connection. The label matters less than knowing which record you are looking at.

03 / CONNECTED MEDICINES

Medicines associated with Depression

Open a field guide for the felt experience, common names, research signal, interactions, contraindications, safety, and legal context unique to each medicine.

WHAT TO CARRY FORWARD

Speed is only one outcome.

A rapid change in a depression score can matter. So can durability, functioning, sleep, adverse effects, access to continuing care, and what happens when symptoms return. Those questions belong beside the acute experience, not after it.